Large doses of common cholesterol-lowering medications appear to reverse coronary artery disease by reducing the amount of plaque in clogged arteries.

U.S. Food and Drug Administration officials have announced that cholesterol-lowering drug fenofibric acid (Trilipix) might not lower a patient's risk of having a heart attack or stroke.

Taking action today will deliever many health benefits tomorrow. Patients who have already had a heart attack or stroke require substantial lifestyle changes to improve their quality of life.

Statins are widely prescribed to lower cholesterol and reduce the risk of heart attacks and strokes. Though effective, some doctors have become concerned about a rare gene that increases the risk of muscle aches, kidney damage and death in those who also take statins.

We all know that eating healthy is better for kids; more fruits, vegetables and fibers, combined with limiting fats and sugars, is better for growing bodies.

Earlier this year, the optimum level for triglycerides was lowered from 150 mg/dL to 100 mg/dL. But doctors aren't suggesting drugs as the main tool to lower them. Instead they're suggesting lifestyle changes are in order.

Hoping someday for an easier way to lower your triglycerides while boosting your "good" HDL cholesterol? For the first time, lab scientists have identified a therapeutic target that may do just that.

Doctors generally monitor how well cholesterol lowering drugs are working through simple blood tests. A high tech method that uses MRI scanning may let them peek inside the arteries to evaluate drug effectiveness.

For some patients, statins simply aren't effective at lowering their high cholesterol. Now scientists think they may have figured out why the cholesterol-lowering drugs don't work well in some patients.

There has been a steady decline in the number of Americans with coronary heart disease in recent years, yet rates vary by race and ethnicity, and residents of some states have a risk that is more than double other geographic regions.